 | Prime Medicine, Inc. | |||
| NGM : PRME || Location: United States | ||||
$4.3-0.4 (-8.51%) |
0.85 M | 4.11 - 4.6 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 10.214 M |
| March 28, 2024 | 9.924 M |
| March 15, 2024 | 9.666 M |
| Feb. 29, 2024 | 9.222 M |
| Feb. 15, 2024 | 10.345 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.52 | -0.72 | -38.49% |
| 09/30/2023 | -0.47 | -0.55 | -17.22% |
| 06/30/2023 | -0.43 | -0.47 | -8.85% |
| 03/31/2023 | -0.42 | -0.44 | -4.19% |
| 12/31/2022 | -0.67 | -0.56 | 15.87% |
PRME Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 119.939M | Shares Float | 57.420M |
| Short Float | 10.214M | Market Cap | 515.74M |
| Institution ownership | 57.79% | Insider ownership | 25.019% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.18 | Forward EPS | -1.63 |